Annual Accounts Payable
$22.67 M
+$5.19 M+29.65%
December 31, 2023
Summary
- As of February 8, 2025, IMCR annual accounts payable is $22.67 million, with the most recent change of +$5.19 million (+29.65%) on December 31, 2023.
- During the last 3 years, IMCR annual accounts payable has risen by +$14.79 million (+187.68%).
- IMCR annual accounts payable is now at all-time high.
Performance
IMCR Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$19.72 M
-$226.00 K-1.13%
September 30, 2024
Summary
- As of February 8, 2025, IMCR quarterly accounts payable is $19.72 million, with the most recent change of -$226.00 thousand (-1.13%) on September 30, 2024.
- Over the past year, IMCR quarterly accounts payable has increased by +$1.92 million (+10.80%).
- IMCR quarterly accounts payable is now -4.38% below its all-time high of $20.62 million, reached on December 31, 2019.
Performance
IMCR Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
IMCR Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.6% | +10.8% |
| 3 y3 years | +187.7% | +229.5% |
| 5 y5 years | +177.3% | +229.5% |
IMCR Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +124.0% | -1.1% | +147.2% |
| 5 y | 5-year | at high | +187.7% | -4.4% | +229.5% |
| alltime | all time | at high | +187.7% | -4.4% | +229.5% |
Immunocore Holdings Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $19.72 M(-1.1%) |
| Jun 2024 | - | $19.95 M(+28.7%) |
| Mar 2024 | - | $15.50 M(-12.9%) |
| Dec 2023 | $22.67 M(+29.7%) | $17.80 M(+30.3%) |
| Sep 2023 | - | $13.66 M(-22.6%) |
| Jun 2023 | - | $17.65 M(+52.7%) |
| Mar 2023 | - | $11.56 M(-20.0%) |
| Dec 2022 | $17.49 M | $14.45 M(+28.9%) |
| Sep 2022 | - | $11.21 M(+40.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $7.98 M(+0.1%) |
| Mar 2022 | - | $7.98 M(-21.2%) |
| Dec 2021 | $10.12 M(+28.4%) | $10.12 M(+69.1%) |
| Sep 2021 | - | $5.99 M(-27.0%) |
| Jun 2021 | - | $8.20 M(+15.5%) |
| Mar 2021 | - | $7.10 M(-9.9%) |
| Dec 2020 | $7.88 M(-61.8%) | $7.88 M(+5.1%) |
| Sep 2020 | - | $7.50 M(-63.6%) |
| Dec 2019 | $20.62 M(+152.2%) | $20.62 M |
| Dec 2018 | $8.18 M | - |
FAQ
- What is Immunocore Holdings annual accounts payable?
- What is the all time high annual accounts payable for Immunocore Holdings?
- What is Immunocore Holdings annual accounts payable year-on-year change?
- What is Immunocore Holdings quarterly accounts payable?
- What is the all time high quarterly accounts payable for Immunocore Holdings?
- What is Immunocore Holdings quarterly accounts payable year-on-year change?
What is Immunocore Holdings annual accounts payable?
The current annual accounts payable of IMCR is $22.67 M
What is the all time high annual accounts payable for Immunocore Holdings?
Immunocore Holdings all-time high annual accounts payable is $22.67 M
What is Immunocore Holdings annual accounts payable year-on-year change?
Over the past year, IMCR annual accounts payable has changed by +$5.19 M (+29.65%)
What is Immunocore Holdings quarterly accounts payable?
The current quarterly accounts payable of IMCR is $19.72 M
What is the all time high quarterly accounts payable for Immunocore Holdings?
Immunocore Holdings all-time high quarterly accounts payable is $20.62 M
What is Immunocore Holdings quarterly accounts payable year-on-year change?
Over the past year, IMCR quarterly accounts payable has changed by +$1.92 M (+10.80%)